Cultured human dermal fibroblasts treated with immune interferon express HLA-DR antigens. We report here that DRpositive fibroblasts present tetanus toxoid (TT) to autologous TT-specific monoclonal helper T cells vigorously depleted of monocytes by passage over Sephadex G10 columns followed by treatment with the monoclonal antibodies (mAb) OKMl and Leu Ml plus complement. The extent of T cell proliferation in response to TT presented by DR-positive fibroblasts was similar to that elicited using monocytes as antigen-presenting cells. The proliferative response was IT dependent, antigen specific, depended upon DR expression by fibroblasts, appeared MHC restricted, and was completely blocked by mouse mAb to HLA-DR but not by mAb to HLA-A,B, or DQ. DR-positive fibroblasts pulsed with Ti were similarly effective in antigen presentation. In summary, immune interferon-stimulated human dermal fibroblasts can substitute for classical antigen-presenting cells in antigen-specific proliferative responses. Since fibroblasts are a ubiquitous cell type in the body, they may play a significant role in the immunobiology of the host.
Introduction
The induction of T lymphocyte responses requires antigen presentation by accessory cells (AC).' Macrophages, as well as epidermal Langerhan's cells (1) (2) (3) , dendritic cells of lymphoid organs (4, 5) , some lymphoblastoid B cell lines (6) (7) (8) , vascular endothelial cells (3, 9) , and brain astrocytes (10) , are capable of AC function and antigen presentation. All of these cells display surface Class II major histocompatibility complex (MHC) antigens (HLA-DR, DP, DQ, or Ia antigens), which are recognized by the responding T cell. Knowledge of the T Recently, we have shown that human class II antigens can be induced on human dermal fibroblasts that are exposed to immune interferon (IFN-'y) (12, 13) . We now report that such HLA-DR-positive fibroblasts are capable of presenting tetanus toxoid (TT) antigen to human antigen-specific monoclonal helper T cells. Thus, IFN-'y-stimulated fibroblasts can substitute for classical antigen presenting cells (APC) in antigen-specific proliferative responses. Since fibroblasts are a ubiquitous cell type in the body, they may play a significant role in the immunobiology of the host.
Methods
Antigens. TT and diphtheria toxoid (DT) were obtained from the Massachusetts Biological Laboratories, Boston, MA. Monilia was obtained from Hollister-Stier Laboratories, Media, PA. All antigens were dialyzed extensively against phosphate-buffered saline (PBS) before use.
Preparation of T cell clones. TT-specific lymphocyte clones were produced by limiting dilution in a manner described by Lamb et al. (14) for influenza specific clones. Briefly, peripheral blood mononuclear cells (PBMC) were HLA-DR on fibroblasts was analyzed by cytotoxicity with standard typing sera or with mAb to DR antigens. In other experiments presence of DR antigens on fibroblasts was assessed by mAb binding quantitated with radioactive second antibody or by cell sorter analysis of trypsinized fibroblasts using fluorescent second antibody as previously described (22). Cultured fibroblasts treated with IFN--y for 96 h were uniformly positive for expression of HLA-DR, DP, and DQ, as reported elsewhere (12, 13) .
Results
Antigen presentation byfibroblasts to T cell clones. Monoclonal T cells specific for the antigen TT were established as previously described (14, 15) . These long-term cloned T cells have been cultured by repeated stimulation (every 7-10 d) with TT in the presence of irradiated autologous PBMC with IL-2-containing supernatants, and were shown to proliferate on exposure to TT in the context of specific HLA-DR antigens on monocytes. Table I shows that significant proliferation of cloned T cells occurred in the presence of TT antigen and autologous monocytes, or with TT and autologous fibroblasts that were pretreated with IFN-'y (lines [3] [4] [5] [6] . Whenever examined in the same experiment, the extent of T cell proliferation to IFN-'ytreated fibroblasts plus TT was similar to that seen in the presence of autologous monocytes (Table I ). The proliferation of both clones F6 and G8 was antigen-and AC-dependent, as it did not occur in the presence of TT alone (Table I , line 2), nor in the presence of IFN-y-treated fibroblasts alone (Table   I , line 5). Untreated fibroblasts failed to present TT to the T cell clones.
Although cloned T cells were maintained without the addition of feeder cells for 14-28 d before testing, and did not proliferate to antigen without the addition of accessory cells (Table I , line 1), it was imperative to demonstrate that the capacity of IFN-'y-treated fibroblasts to stimulate antigenspecific proliferation of the T cell clones was not dependent on the presence of residual monocytes contaminating the T cell clones. Cloned T cells were therefore passed over Sephadex G10, treated with OKM1 and Leu Ml plus complement, then examined for their proliferative response to TT. Such treatment, when applied to PBMC, results in total loss of proliferation to (Table IV) . However, fibroblasts that were not pretreated with IFN-y, but which were pulsed with TT, were not effective in stimulating proliferation.
Role of HLA-DR antigens. The role of HLA-DR antigens on IFN-'y-pretreated fibroblasts in T cell proliferation in response to antigen was examined. A panel of HLA-DR-typed fibroblasts was used to present antigen to clone G8. This clone was derived from an HLA-DR3,5-positive donor, and was shown to be HLA-DR5 restricted (reference 15 and Table V) . Among the eight allogeneic fibroblast lines tested, three of three HLA-DR5(+) lines presented TT antigen to G8, whereas none of four (0/4) HLA-DR5(-) fibroblast lines presented TT antigen to G8 (Table V) . Monocytes were available from two of the four HLA-DR5(-) donors whose fibroblasts were tested. In both cases the monocytes failed to present TT to G8. Thus, there was complete concordance with respect to antigen presentation by monocytes versus fibroblasts in the five instances where monocytes and fibroblasts were available from the same donor.
It was imperative to show that IFN-y-treated HLA-DR5(-) fibroblasts, which failed to present antigen to clone G8, could present antigen to HLA-DR homologous T cell clones. A TTspecific T cell clone (C1) was generated from the HLA-DR2,8 donor shown in Table V present antigen to the DR5-restricted clone G8 (Table V) was not caused by an intrinsic inability of the fibroblasts to present antigen. Taken together, these results suggested that the presentation of antigen by IFN-y-treated fibroblasts to T cells was MHC restricted. We next examined the effect of mAb to HLA-DR on antigen presentation by IFN-y-treated fibroblasts. Table VII shows that addition of monoclonal anti-HLA-DR (LB3.1) to the cultures abolished T cFll proliferation. In contrast, monoclonal anti-HLA-A,B (W6/32), monoclonal anti-DC (Leu 10), and an irrelevant mAb (UPC 10) did not inhibit T cell proliferation. The blocking by LB3. 1 was not an isotype effect because BBM.1, an antibody reactive with B2 microglobulin, and of the same immunoglobulin subclass as LB3.1, bound fivefold more to fibroblasts, yet failed to inhibit the proliferation of T cell clones to antigen presented by autologous IFN-ytreated fibroblasts (data not shown). Furthermore, inhibition of the antigen response by anti-HLA-DR was not simply due to binding of the antibody to the HLA-DR antigen on cloned T cells, because proliferation of the cloned T cells in response to IL-2-containing supernatants was not affected by these antibodies.
The Ia specificity of the inhibition of LB3. 1 was confirmed with another mAb to human HLA-DR (ST2-59), which also inhibited T cell proliferation in response to TT presented by autologous IFN-y-treated fibroblasts, but not in response to IL-2. Fig. 1 depicts the dose dilution curve of ST2-59 on the inhibition of proliferation of G8 and F6. The proliferation of G8 and F6 in response to antigen presented by Ia-positive fibroblasts was inhibited even by low concentrations of ST2-59. In contrast, ST2-59 did not significantly affect the response of these T cell clones to IL-2. These data taken together support the idea that HLA-DR antigens induced by IFN-y on fibroblasts allow antigen-specific, Ia-restricted proliferation of clones to occur.
Antigen presentation to peripheral blood T cells. The ability of fibroblasts to present TT to autologous resting T cells was examined next. PBMC were depleted of monocytes by adherence to plastic (performed twice), then by passage over Sephadex G 10. Values represent mean cpm±SD for triplicate cultures. Culture conditions and pretreatment of fibroblasts with IFN-'y were as in Table I .
Fibroblasts-IFN--y, IFN-y-treated fibroblasts. Both Clone Cl and fibroblasts were derived from the HLA-DR2, 8 donor of Table V. MHC antigens, are capable of presenting soluble protein antigen to T lymphocytes in an MHC-restricted manner. Several lines of evidence make it unlikely that some nonfibroblast cell type in our culture was responsible for antigen presentation. First, it is unlikely that the fibroblast cultures were contaminated by classical APC, since these lines have been propagated at least through 20 population doublings (minimum of 10 subcultures at 1:4 split ratios). The hypothetical contaminating cells in the fibroblast cultures would have to be capable of extensive propagation (i.e., not a typical macrophage), and would require IFN-'y pretreatment to be able to present antigen, which implies that it would be Ia-negative until induction; i.e., not a typical dendritic cell. Although our fibroblasts are not cloned, they were morphologically homogeneous and uniformly Ia inducible by Second, it is also unlikely that the T cell clones were contaminated to any significant extent with APC, which were derived from the irradiated PBMC that were added periodically to maintain these clones. AC activity of such feeder cells is unlikely to have remained as long as 14-28 d after irradiation, the time at which these clones were used. Such clones indeed could not respond to TT in the absence of additional accessory cells (Table I) . Furthermore, passage ofthe clones over Sephadex GO0 followed by lysis with anti-OKM 1 and Leu Ml plus complement did not affect their ability to respond to antigen presented by IFN-"y fibroblasts (Table II) . If, despite all these efforts, a contaminating accessory cell remained in our T cell clone preparations, then, at the very least, MHC compatible Ia(+) fibroblasts would be required for that residual accessory cell to express its function (Table V) . Thus, the fact that antigen presentation to T cell clones by fibroblasts appeared MHC restricted, argues strongly that the APC was derived from the fibroblast cultures, and not from the T cells.
Our present experiments characterize antigen presentation by human dermal fibroblasts. First, Ia-positive fibroblasts, but not Ia-negative fibroblasts, stimulate antigen-specific T cell proliferation in cloned T cells (Tables I and IV) . Second, antigen-pulsed Ia-positive fibroblasts effectively induce T cell proliferation, which suggests that these cells have the intrinsic capacity to take up and present antigen (Table IV) . Third, antigen presentation by fibroblasts to cloned T cells appears to involve fibroblast DR-antigens, as evidenced both by MHC restriction and by inhibition with mAb to HLA-DR antigens (Tables V and VII, Fig. 1 Katz and Unanue (23) reported that mouse embryo fibroblasts pulsed with DNP-KLH caused the development of a significant anti-DNP plaqueforming cell response in whole spleen cell cultures, the spleen cells used were not depleted of macrophages, and it remained unclear which APC stimulated the T lymphocytes. Lipsky et al. (24) showed that guinea pig kidney fibroblasts could reconstitute the proliferative response of purified T cells to phytohemagglutinin, but not to the tuberculin antigen. Similar results were reported by Raff (25) using mouse embryo fibroblasts. Thus, fibroblasts, which normally do not express Ia antigens, failed to present protein antigens to T cells. This idea was consistent with the dictum that la expression is necessary for protein antigen presentation. Recently, Hood and coworkers (26) have transferred genes for Ia antigens into mouse fibroblasts. Expression of these genes allowed such fibroblasts to stimulate antigen-specific T cell hybridomas to secrete IL-2. Our experiments have used a physiologic stimulus, i.e., IFNy, to induce Ia expression on fibroblasts, which then presented antigen and induced proliferation of T cells.
In vivo fibroblasts do not normally display surface Ia antigens. As in the case of macrophages (27) , modulation of la expression on fibroblasts may be a mechanism by which their antigen presenting activity is regulated. Positive modulation of la expression in fibroblasts with IFN-'y secreted by T cells (28) (29) . Thus, it appears that the requirements to activate a resting T cell may be best provided by a cell of monocyte/ macrophage lineage, but the requirements for activation of cloned T cells can be easily met by multiple Ia(+) cell types.
